Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Thrombotic Thrombocytopenic Purpura in a Newborn

Abstract

This report describes a newborn who presented with hyperbilirubinemia and thrombocytopenia. The patient recovered after treatment with antibiotics, phototherapy, and a platelet transfusion. Analysis of the plasma von Willebrand factor–cleaving metalloprotease, ADAMTS13, revealed low protease activity in the patient and her two siblings, and a mild deficiency in both parents. These results confirmed the clinical suspicion of hereditary thrombotic thrombocytopenic purpura (TTP). Although most cases of thrombocytopenia and hyperbilirubinemia in the newborn period are caused by other causes, genetic deficiency of ADAMTS13 may not be as uncommon as previously believed. Early diagnosis may have important implications for the patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Schulman I, Pierce M, Lukens A, Currimbhoy Z . Studies on thrombopoiesis: I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency. Blood 1960; 16: 943–57.

    CAS  PubMed  Google Scholar 

  2. Upshaw JD Jr . Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med 1978; 298: 1350–2.

    Article  Google Scholar 

  3. Chintagumpala MM, Hurwitz RL, Moake JL, et al. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr 1992; 120: 49–53.

    Article  CAS  Google Scholar 

  4. Nathanson S, Fremeaux-Bacchi V, Deschenes G . Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency. Pediatr Nephrol 2001; 16: 554–6.

    Article  CAS  Google Scholar 

  5. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488–94.

    Article  CAS  Google Scholar 

  6. Furlan M, Robles R, Solenthaler M, et al. Acquired deficiency of von Willebrand factor–cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998; 91: 2839–46.

    CAS  PubMed  Google Scholar 

  7. Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor–cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. N Engl J Med 1998; 339: 1578–84.

    Article  CAS  Google Scholar 

  8. Tsai HM, Lian EC . Antibodies to von Willebrand factor–cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585–94.

    Article  CAS  Google Scholar 

  9. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939–50.

    CAS  PubMed  Google Scholar 

  10. Tsai HM . Von Willebrand factor, ADAMTS13 and thrombotic thrombocytopenic purpura. J Mol Med 2002; 80: 639–47.

    Article  CAS  Google Scholar 

  11. Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K . Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 1985; 38: 467–79.

    Article  Google Scholar 

  12. Tsai HM, Li A, Rock G . Inhibitors of von Willebrand factor–cleaving protease in thrombotic thrombocytopenic purpura. Clin Lab 2001; 47: 387–92.

    CAS  PubMed  Google Scholar 

  13. te Loo DM, Levtchenko E, Furlan M, et al. Autosomal recessive inheritance of von Willebrand factor–cleaving protease deficiency. Pediatr Nephrol 2000; 14: 762–5.

    Article  CAS  Google Scholar 

  14. Allford SL, Harrison P, Lawrie AS, et al. Von Willebrand factor–cleaving protease activity in congenital thrombotic thrombocytopenic purpura. Br J Haematol 2000; 111: 1215–22.

    Article  CAS  Google Scholar 

  15. Sasahara Y, Kumaki S, Ohashi Y, et al. Deficient activity of von Willebrand factor–cleaving protease in patients with Upshaw-Schulman syndrome. Int J Hematol 2001; 74: 109–14.

    Article  CAS  Google Scholar 

  16. Mannucci PM, Canciani MT, Forza I, et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730–5.

    Article  CAS  Google Scholar 

  17. Katz JA, Moake JL, McPherson PD, et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989; 73: 1851–8.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ann Becker, Debbie Fearing, and Darryl Hake for their help and dedication to patient care.

Author information

Authors and Affiliations

Authors

Additional information

This study was supported, in part, by a grant (R01 HL62131 to H.-M.T.) from the National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jubinsky, P., Moraille, R. & Tsai, HM. Thrombotic Thrombocytopenic Purpura in a Newborn. J Perinatol 23, 85–87 (2003). https://doi.org/10.1038/sj.jp.7210853

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210853

This article is cited by

Search

Quick links